澳洲北方地区禁止未满18岁者的青春期阻塞者, 激起对变性青年精神健康影响的批评。 Australia’s Northern Territory bans puberty blockers for under-18s, sparking criticism over impacts on transgender youth mental health.

澳洲北区禁止未满18岁者的青春期阻塞器, 加入昆士兰州限制获得治疗, Australia’s Northern Territory has banned puberty blockers for under-18s, joining Queensland in restricting access to the treatment, citing concerns over irreversible effects and so-called "ideologically driven practices." 这一举动影响到少数青年,但引起了医学专家和倡导者的批评,他们说,这种举动限制了获得支持心理健康和身份探索的安全、可逆转治疗的机会,从而伤害了变性人和变性人。 The move affects a small number of youth but has drawn criticism from medical experts and advocates who say it harms transgender and gender-diverse minors by limiting access to a safe, reversible treatment that supports mental health and identity exploration. 虽然两个管辖区都援引了有限的长期证据——在英国2031年应进行的审判之前——保健专业人员强调在治疗的安全和临床价值方面现有的共识。 While both jurisdictions cite limited long-term evidence—pending a UK trial due in 2031—health professionals emphasize existing consensus on the treatment’s safety and clinical value. 批评者认为,禁令是出于政治动机,有可能使本已脆弱的群体更加痛苦。 Critics argue the bans are politically motivated and risk worsening distress among an already vulnerable group. 预计会有法律挑战,支助服务仍然可用。 Legal challenges are expected, and support services remain available.